Title: Design, synthesis, and pharmacological evaluation of haloperidol derivatives as novel potent calcium channel blockers with vasodilator activity.
Journal: PloS one 20110101
116373-23-0
1171506-89-0
1159826-27-3
124257-62-1
1245794-60-8
1289388-64-2
1491969-77-7 | tert-Butyl 4-(carbamothioylmethyl)piperidine-1-carboxylate | AA01C574 | MFCD29051124
1521612-18-9 | 6-fluoro-2-[(piperidin-4-yl)methyl]-1,3-benzoxazole | AA01C5B3 | MFCD24883117
1955555-00-6 | 2-(pyrrolidin-3-yl)-1H-imidazole dihydrochloride | AA01C5FH | MFCD28893652
1969288-42-3 | rac-(2R,5S)-5-[(1H-imidazol-1-yl)methyl]oxolane-2-carboxylic acid hydrochloride, cis | AA01C5JC | MFCD30011406
1550922-57-0 | 2-methoxy-N-(2-methylpropyl)pyridin-4-amine | AA01C5OK | MFCD24251375
1820648-98-3 | 2,7-Dimethoxy-1,8-naphthyridine-4-carbaldehyde | AA01C634 | MFCD29038162
468718-69-6 | N-(3-chloropyridin-2-yl)-2,2-dimethylpropanamide | AA01C6E7 | MFCD02055129
1341152-81-5 | ethyl 5-(methoxymethyl)-1-methyl-1h-1,2,4-triazole-3-carboxylate | AA01C6JB | MFCD18344474
1337410-09-9 | 3-(cyclopropylmethyl)morpholine | AA01C74N | MFCD24496379
1248707-89-2 | 2,2-dimethyl-1-(3-methylpyridin-2-yl)propan-1-one | AA01C7J4 | MFCD16748766